PEACCEL is positioned to be a partner of choice in AI for our clients all along the continuum of drug development process, from discovery to pre-clinical and clinical trials. We accompany our partners with our innovative technological platform and with our skilled, agile and focused team which results in a faster, cheaper and de-risked advancement of programs.
Read our latest news !
PEACCEL mentioned as a AI start-up to watch by NVIDIA. Three Trends for Healthcare AI Startups To Watch Renee Y. |…
PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021: Market report by Cision (NYSE: CISN). https://www.prnewswire.com/news-releases/global-ai-based-drug-discovery-market-report-2021-current-market-landscape-and-future-potential-of-the-players-engaged-in-offering-ai-based-services-platforms-and-tools—forecast-to-2030-301231782.html